Biotech Public

Hosted by:

10:30

10:45

11:00

11:15

11:30

11:45

12:00

12:30

12:45

13:00

13:15

13:30

13:45

14:00

14:30

14:45

15:00

15:15

15:30	PANEL: Getting Ahead: Expectations For The Biotech Public Markets in 2024 As the public markets experience downturns, it's essential to reflect on industry-wide transformations and explore new strategies for the future. In this session, we will delve into innovative approaches to financing, operations, and partnerships that collectively build a robust toolkit for biotech survival. Join us as we navigate the recovery from past challenges, examining how to adapt and thrive in the ever-changing landscape. Discover the keys to resilient growth and gain insights into the technical tools that will secure the future of biotech companies. How are some of the country’s leading investors viewing the public markets at the moment? How can certain business operations be streamlined to ensure capital is deployed efficiently during tough times? Strategies to finance the business How can the industry respond to the current public markets? Tim Haines, Managing Director, Abingworth Simone Botti, Partner, INKEF Capital Jasper Bos, General Partner, Forbion

16:00

16:15

16:30

16:45

17:00	Drinks Reception

18:00	Close of Investival Showcase

18:30	Awards & Gala Dinner - Separate ticket required - Find out more